ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Marker Therapeutics, Inc. - Common Stock (NQ:MRKR)

1.505 -0.015 (-0.97%)

Streaming Delayed Price Updated: 10:55 AM EST, Dec 30, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	90,874
Open	1.500
Bid (Size)	1.500 (900)
Ask (Size)	1.520 (400)
Prev. Close	1.520
Today's Range	1.490 - 1.542
52wk Range	0.8099 - 4.070
Shares Outstanding	8,923,490
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Marker Therapeutics Stock Drops After Report About Lymphoma Treatment ↗

August 26, 2025

Marker Therapeutics reports strong safety and efficacy data for MT-601 in lymphoma patients, with durable responses and no serious adverse events.

Via Benzinga

Tuesday's pre-market session: top gainers and losers ↗

August 26, 2025

Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.

Via Chartmill

Performance

YTD	-52.7%	-52.7%
1 Month	+27.6%	+27.6%
3 Month	+62.5%	+62.5%
6 Month	-1.6%	-1.6%
1 Year	-54.9%	-54.9%

More News

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 17, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

July 17, 2025

Via Chartmill

Gapping stocks in Thursday's session ↗

July 17, 2025

Via Chartmill

Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings ↗

July 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 14, 2025

Via Benzinga

Which stocks have an unusual volume on Monday? ↗

March 10, 2025

Via Chartmill

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

March 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 05, 2024

Via Benzinga

MRKR Stock Earnings: Marker Therapeutics Beats EPS for Q2 2024 ↗

August 14, 2024

Via InvestorPlace

MRKR Stock Earnings: Marker Therapeutics Reported Results for Q4 2023 ↗

June 28, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 05, 2024

Via Benzinga

MRKR Stock Earnings: Marker Therapeutics Reported Results for Q1 2024 ↗

May 15, 2024

Via InvestorPlace

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization ↗

January 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 29, 2023

Via Benzinga

Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 12/11

December 11, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 11, 2023

Via Benzinga

Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today? ↗

September 11, 2023

Via Benzinga

Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies

August 17, 2023

Via Newsfile

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 09, 2023

Via InvestorPlace

Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 11, 2023

Via Benzinga

Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session ↗

July 31, 2023

Via Benzinga

Frequently Asked Questions

Is Marker Therapeutics, Inc. - Common Stock publicly traded?

Yes, Marker Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Marker Therapeutics, Inc. - Common Stock trade on?

Marker Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Marker Therapeutics, Inc. - Common Stock?

The ticker symbol for Marker Therapeutics, Inc. - Common Stock is MRKR on the Nasdaq Stock Market

What is the current price of Marker Therapeutics, Inc. - Common Stock?

The current price of Marker Therapeutics, Inc. - Common Stock is 1.505

When was Marker Therapeutics, Inc. - Common Stock last traded?

The last trade of Marker Therapeutics, Inc. - Common Stock was at 12/30/25 10:55 AM ET

What is the market capitalization of Marker Therapeutics, Inc. - Common Stock?

The market capitalization of Marker Therapeutics, Inc. - Common Stock is 13.43M

How many shares of Marker Therapeutics, Inc. - Common Stock are outstanding?

Marker Therapeutics, Inc. - Common Stock has 13M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.